Role and hallmarks of Sp1 in promoting ovarian cancer
Ovarian cancer has a poor prognosis especially due to late diagnosis, intrinsic resistance to some therapeutic drugs, increased interest in finding novel DNA – binding and transcription factor agents as a probable chemotherapy in treating ovarian the gynecological cancer. Based on many previous repo...
Saved in:
Main Authors: | Iyer Mahalaxmi, K.S. Santhy |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2018-08-01
|
Series: | Journal of Oncological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452336418300074 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aging and cancer hallmarks as therapeutic targets
by: Jingchao Wang, et al.
Published: (2023-06-01) -
Diversity and hallmarks of metabolites surveyed by MR1
by: Emi Ito, et al.
Published: (2025-07-01) -
Molecular Hallmarks of Gliomas
by: Pojo, Marta, et al.
Published: (2011) -
Multinucleated giant cells are hallmarks of ovarian aging with unique immune and degradation-associated molecular signatures.
by: Aubrey Converse, et al.
Published: (2025-06-01) -
Multinucleated giant cells are hallmarks of ovarian aging with unique immune and degradation-associated molecular signatures
by: Aubrey Converse, et al.
Published: (2025-06-01)